Wednesday, January 22, 2025

Bivalent boosters against COVID-19 authorized for children

bivalent reinforcements
Photo:P360P

The Food and Drug Administration (FDA) has authorized the use of bivalent booster doses of the COVID-19 vaccine for children ages five and up.

Moderna's bivalent COVID-19 vaccine and Pfizer-BioNTech's vaccine have been authorized for use as booster shots in children up to five years of age.

In addition, this booster is capable of protecting against the Omicron variants and its BA.4 and BA.5 lineages.